Spahn et al. reported that an ultrashort-term treatment of isolated ID resulted in a higher postoperative Hb and reduced transfusions of allogeneic blood products in anemia patients with no significant negative side-effects (18). The gene discussed is GSTM1; the disease is anemia (phenotype).